Diagnostic Regional Medical Lead, Oncology Breast – Southeast

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Job Summary

The Diagnostic Regional Medical Lead (Director Level) is a hybrid headquarters and field-based position that will provide diagnostic leadership of the Medical Diagnostic strategy and have field-based liaison responsibilities supporting the Southeast region of the US (TN, NC, SC, MS, AL, GA, FL).  This role will collaborate with relevant business partners to develop, align and execute the Medical Diagnostic strategy with external stakeholders.  The candidate will identify and develop on-going professional relationships with key national and regional leaders in the diagnostic and biomarker areas in select oncology tumor types. Additionally, the Principal Medical Diagnostics Liaison, Pathology develops skills and competencies to educate healthcare professionals and DSI internal stakeholders, including but not limited to Clinical Development, Clinical Development Operations, Medical Research and Strategy, Commercial, Biomarkers and Companion Diagnostics (CDx).

Commercial, Biomarkers and Companion Diagnostics (CDx).

Responsibilities
Scientific Engagement:

• Support strategy development and own the execution of biomarker diagnostic readiness programs (launch plans and budgets)
• Develop external engagement strategy, facilitate engagements and build relationships with key leaders in the diagnostic and biomarker area, including clinical experts and specialized pathologists
• Establish and foster working relationships with CAP, USCAP, ASCP, and regional pathology societies
• Identify opportunity and selectively manage relationships with strategic partners, including advocacy, payer and provider groups
• Recommend and deliver diagnostics-focused educational content targeted to KMEs in the diagnostic and biomarker areas (primarily pathologists)
• Identify and appropriately facilitate external engagement related to biomarker evidence generation plans
• Drive dedicated pathology-centered trainings according to interpretation guides and ASCO/CAP guidelines; perform in person and virtual slide reviews
• Educate on clinical risk mitigation and impact of diagnostic choice on patient management
• Gather pathology-related external medical insights regarding DSI investigational products to help inform Clinical Development and US Medical strategy
• Respond to unsolicited requests for medical information

Strategic Planning and Project Management:

• Evaluate and contribute expertise to the US diagnostic strategy for current and future DSI oncology products
• Collaborate with relevant internal business partners (e.g., HEOR, HOL) to assist with design and execution of HEOR studies, outcomes surveys, etc. related to diagnostics
• Identify and assist in leading solution-based strategies to address biomarker adoption, barriers, and gaps
• Lead special projects/initiatives, as needed, in support of US Medical Affairs diagnostics strategy

Qualifications

The successful candidate will be able to meet the qualifications below with or without reasonable accommodation

Education/Experience

Qualified candidates will have the following: 

• Advanced scientific degree (PhD, PharmD or MD) preferred; equivalent will be considered with relevant experience in diagnostic and biomarker area
• At least 5+ years of related work experience in industry, clinical, or research institution with emphasis in pathology 
• Strong business acumen, including understanding of drivers behind evolving diagnostic landscape
• Strong analytical and problem-solving skills while demonstrating strategic thinking, leading, and delivering outcomes
• Deep understanding of diagnostic FDA environment, clinical laboratory practices including CAP/CLIA lab requirements and test implementation
• Proven track record of strategic thinking, judgment, and influencing skills
• Ability to independently lead, initiate, manage, develop, and deliver initiatives/projects
• Strong knowledge of medical strategy, clinical diagnostic development, and Field Medical activities
• Clear demonstration of effective cross-functional project team collaboration
• Proven ability to interact productively with both commercial and scientific / medical colleagues
• Demonstrated experience with developing and executing strategic plans
• Demonstrated leadership abilities in a matrix organization
• Experience in engaging with external experts
• Exceptional teamwork and collaboration skills
• Excellent written and oral communication, interpersonal, and organization skills.
• Ability to travel up to 50% of the time, including overnight.

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.